Pharmamarketeer

EMA/US FDA analysis shows high degree of alignment in marketing application decisions between EU & US

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are aligned in more than 90 per cent of marketing authorisation decisions for new medicines.

Medhc-fases-banner
Advertentie(s)